• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Astrazeneca Plc ADR (NQ: AZN )

    65.85 +1.59 (+2.47%)
    Streaming Delayed Price Updated: 1:02 PM EST, Nov 22, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 4,004,060
    Open 65.70
    Bid (Size) 65.85 (6)
    Ask (Size) 65.86 (2)
    Prev. Close 64.26
    Today's Range 65.61 - 66.45
    52wk Range 60.47 - 87.67
    Shares Outstanding N/A
    Dividend Yield 1.52%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    AstraZeneca's Andexxa Faces FDA Scrutiny Over Effectiveness, Safety Concerns
    FDA panel to discuss AstraZeneca's supplemental application for Andexxa amid safety concerns, including thrombosis risks and efficacy limitations. 
    Via Benzinga
    Exposures Product Safety
    3 Growth Stocks Trading Near Their 52-Week Lows to Buy Right Now
    Via The Motley Fool

    Performance

    YTD
    -3.73%
    -3.73%
    1 Month
    -14.83%
    -14.83%
    3 Month
    -23.33%
    -23.33%
    6 Month
    -15.77%
    -15.77%
    1 Year
    +3.52%
    +3.52%

    More News

    Read More
    This AstraZeneca Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday
    Via Benzinga
    AstraZeneca awards $3.5M for projects to improve access to healthcare for patients across the US
    From AstraZeneca
    Via Business Wire
    Earnings Scheduled For November 12, 2024
    Via Benzinga
    A Closer Look at AstraZeneca's Options Market Dynamics
    Via Benzinga
    Not-So-Big Pharma
    Via Talk Markets
    European And US Vaccine Stocks Are Under Pressure - Here's WHy
    Via Benzinga
    Exposures Product Safety
    Jim Cramer Says This Tobacco Stock Is 'Undervalued' But He's Not Recommending It
    Via Benzinga
    WHO Calls Vaccines 'Absolutely Critical' As Trump's Appointment Of RFK Jr Pulls Pzifer, Moderna Stocks Downhill
    Via Benzinga
    Topics Government
    Exposures Political
    Trump Taps RFK Jr. For Health Secretary Role, Sends 5 Vaccine Stocks Lower
    Via Benzinga
    Topics Government
    Exposures Political
    Is AstraZeneca a Buy as It Eyes the Weight Loss Market?
    Via The Motley Fool
    Regeneron/Sanofi's Dupixent Approval Signals Major Treatment Breakthrough For Smokers' Lung Disease
    Via Benzinga
    AstraZeneca Plc (AZN) Q3 2024 Earnings Call Transcript
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    AstraZeneca Lifts 2024 Forecast On Better Than Expected Q3 Performance, Says It Takes China Investigations 'Very Seriously'
    Via Benzinga
    AstraZeneca Stock Dives As China's Criminal Probe Rattles Its Third-Quarter Beat
    Via Investor's Business Daily
    AstraZeneca invests $3.5 billion in R&D and manufacturing in the United States
    From AstraZeneca
    Via Business Wire
    AstraZeneca’s 9M and Q3 2024 results
    From AstraZeneca
    Via Business Wire
    The Week Kamala Harris Lost (Nov 4-8), These Large Cap Stocks Lost Big
    Via Benzinga
    AstraZeneca Q3 Earnings Preview: Will Cancer, Heart Drugs Fuel Continued Growth?
    Via Benzinga
    AstraZeneca/Amgen's Asthma Drug Aces Late-Stage Study In Patients With Chronic Rhinosinusitis
    Via Benzinga
    TEZSPIRE met both co-primary endpoints in the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps
    From AstraZeneca
    Via Business Wire
    AstraZeneca showcases strength of hematology portfolio and pipeline at ASH 2024
    From AstraZeneca
    Via Business Wire
    Upstream Bio Is New On NASDAQ, Can Potentially Beat AstraZeneca's Asthma Drug On Efficacy, Analysts Say
    Via Benzinga
    Why Is AstraZeneca Stock Sinking On Tuesday?
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.